OTC · Financial Statements

Better Therapeutics, Inc. (BTTX) Financial Statements

$0.00 OTC: BTTX Market Cap $5452

Better Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-40.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2019202020212022
Revenue$0$0$0$0
Operating Profit$-6.0M$-6.0M$-31.0M$-38.0M
Net Profit$-6.0M$-6.0M$-40.0M$-40.0M
EPS$-0.25$-1.04$-1.71$-1.69
Op Margin-32072.2%-79037.5%——

Balance Sheet (USD)

Metric2019202020212022
Total Assets$5.0M$6.0M$51.0M$23.0M
Total Liabilities$5.0M$13.0M$14.0M$24.0M
Cash$1.0M$0$41.0M$16.0M
Borrowings$5.0M$1.0M$10.0M$15.0M

Cash Flow (USD)

Metric2019202020212022
Operating Cash Flow$-6.0M$-6.0M$-31.0M$-29.0M
Investing Cash Flow$-5.0M$-5.0M$-3.0M$-2.0M
Financing Cash Flow$0$4.0M$59.0M$0
Net Cash Flow$0$-1.0M$40.0M$-25.0M
Free Cash Flow$-9.0M$-8.0M$-32.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.02
FCF Yield-552274.39%
Quick Ratio1.37
Interest Coverage-25.66
Return 1Y0.00%
Return 3Y-99.99%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
BTTX Overview BTTX Dividend Run Stock Screener